Unlock instant, AI-driven research and patent intelligence for your innovation.

Extract with anti-tumor and anti-poisonous activity

An extract and active technology, applied in the medical field, can solve problems such as limiting long-term treatment

Inactive Publication Date: 2005-12-21
UNIBIOSCREEN SA
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, until now, this type of compound is also known to have significant toxic side effects, thus limiting its use for long-term treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Extract with anti-tumor and anti-poisonous activity
  • Extract with anti-tumor and anti-poisonous activity
  • Extract with anti-tumor and anti-poisonous activity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0220] Embodiment 1 extracts the method for the extract of the present invention from plant white-flowered horned melon

[0221] The extract of the present invention (Extract A) was extracted with methanol from the root of the crocus plant (Romoaceae). The extract is also referred to as Extract A (number). Put 10 g of plants into a Erlenmeyer flask containing 150 ml of methanol, stir with a magnetic force for 12 hours, and then filter through fritted glass. The solid residue was extracted with methanol for an additional 2 hours. The two filtrates were combined and evaporated under vacuum using a rotary evaporator. The residue containing the methanolic extract was named Extract A.

[0222] Extract A was analyzed to contain several types of compounds. There is a special group of compounds in the extract A consisting of cardiotonic steroids, such as ashalogenoside, calactin, vorusharin, acrotoxin, acrogenin, ousalogenin, calotoxin, usharin and usharidin. In addition, other ...

Embodiment 2

[0234] Example 2 Effect of the extract of the present invention on the overall growth of cell line cells

[0235] This example illustrates the antitumor activity of the extract A of the present invention on different types of tumors. In order to characterize the in vitro activity of Extract A, the MTT assay of Extract A was performed. The MTT assay is an indirect assay well known in the art that can rapidly, ie within 5 days, determine the effect of a given product on the overall growth of a cell line. The test can detect the number of metabolically active living cells, because living cells can reduce the yellow MTT product (3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyl tetra azole olfactory compound) into the blue product formazan, which can only be produced by living cells. The amount of formazan formed at the end of the test was measured by a spectrophotometer, and its value was proportional to the number of viable cells.

[0236] The 48 human tumor cell lines described in T...

Embodiment 3

[0254] Embodiment 3 The influence of the extract of the present invention on cell dynamics

[0255] This example illustrates the cell proliferation inhibitory effect of extract A of the present invention. From the results of the MTT colorimetric analysis described in Example 2, it can be clearly seen that the extract A can significantly inhibit the overall growth level of most of the 48 human cancer cell lines analyzed in the MTT test. In the following examples, it is necessary to analyze whether the inhibitory effect of the extract on cell growth is caused by changes in cell cycle dynamics (Example 3), or due to the induction of apoptosis (Example 4), or both factors exist.

[0256] The cell cycle is generally divided into the following phases: G0 / G1, S and G2 / M phases. Alterations in proteins that regulate cell proliferation and / or cell death are the targets of the active compounds in Extract A. Changes in cell cycle kinetics can be measured by flow cytometry with differe...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Extracts of the plant Calotropis procera, having a pharmacological activity, in particular an anti-poisonous activity, and active compounds isolated thereof are described. Furthermore, methods for the extraction of the extracts are disclosed. Also, a pharmaceutical composition or product for the treatment of cancer which includes an effective amount of the described extracts or an active compound thereof, a therapeutic compound and optionally a pharmaceutical acceptable carrier are described.

Description

field of invention [0001] The present invention relates to the field of medicine. A first aspect of the present invention relates to extracts from the plant Calotropis procera having pharmacological activity, in particular antitumor activity and / or antitoxic activity, and active compounds isolated therefrom. A second aspect of the invention relates to a method of obtaining said extract. The third aspect of the present invention also relates to a pharmaceutical composition for cancer treatment, which composition comprises an effective amount of the extract or its active compound. The fourth aspect of the present invention relates to the use of the extract or its active compound as medicine and the use of the extract or its active compound in the preparation of anticancer drugs. Background of the invention [0002] Tumors arise when genomic mutations in certain tissues interfere with cell cycle dynamics, resulting in excessive cell proliferation or reduced cell death. This ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/27A61P35/00A61P39/00
CPCA61K36/27A61P35/00A61P39/00A61P39/02
Inventor F·达罗J·-C·布拉克曼P·古索O·G·纳科尔马M·艾尔雅兹迪J·德维勒R·范金克尔M·范 达默R·基斯
Owner UNIBIOSCREEN SA